Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 80 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 8501740

    Methods of treatment of opioid tolerance, physical dependence, pain and addiction with inhibitors of certain growth factor receptors

    The Board of Regents of the University of Texas System · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  2. US 8501713

    Drug combinations for the treatment of duchenne muscular dystrophy

    Summit Corporation Plc · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  3. US 8501704

    Immunosuppression compound and treatment method

    Sarepta Therapeutics, Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  4. US 8496957

    Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  5. US 8497258

    Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  6. US 8497279

    Treatment for discoid lupus

    Rigel Pharmaceuticals, Inc. · Granted Jul 30, 2013 · Expires Jul 25, 2033

    granted

  7. US 8491883

    Treatment of amyotrophic lateral sclerosis using umbilical derived cells

    Advanced Technologies and Regenerative Medicine, LLC · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  8. US 8491886

    Viruses for the treatment of cellular proliferative disorders

    ONCOLYTICS BIOTECH INC. · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  9. US 8492347

    Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus

    The Regents of the University of California · Granted Jul 23, 2013 · Expires Jul 18, 2033

    granted

  10. US 8486391

    Cancer treatment kits using antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  11. US 8486965

    Pyrrolo[2,3-b]pyridine derivative and use thereof for treatment of cancer

    Takeda Pharmaceutical Company Limited · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  12. US 8486923

    Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis

    TAKEDA GMBH · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  13. US 8486909

    Compositions and methods for the diagnosis and treatment of inflammatory disorders and fibrotic disease

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  14. US 8481038

    Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins

    Five Prime Therapeutics, Inc. · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  15. US 8481757

    Compounds and compositions useful in the treatment of malaria

    The Regents of the University of California · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  16. US 8481760

    Inhibition and treatment of prostate cancer metastasis

    Northwestern University · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  17. US 8476236

    Treatment of skin conditions by Dickkopf1 (DKK1)

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 2, 2013 · Expires Jun 27, 2033

    granted

  18. US 8470296

    Intracorporeal medicaments for high energy phototherapeutic treatment of disease

    Provectus Pharmatech, Inc. · Granted Jun 25, 2013 · Expires Jun 20, 2033

    granted

  19. US 8465746

    Compositions and methods for treatment, research and therapeutic applications for malaria

    Northwestern University · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted

  20. US 8465743

    Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted

  21. US 8461203

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Jazz Pharmaceuticals, Inc. · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  22. US 8461153

    Benzodiazepinone compounds useful in the treatment of skin conditions

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 11, 2013 · Expires Jun 6, 2033

    granted

  23. US 8455553

    Methods and compositions for prevention and treatment of inflammatory disease, autoimmune disease and transplant rejection

    The Regents of the University of California · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  24. US 8454965

    Method for the treatment of multiple sclerosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.